Tandem Diabetes Care Inc（TNDM）资讯与事件TNDMTandem Diabetes Care Inc

Tandem Diabetes Care Launches Insulin Pump Compatible with Abbott Sensor

Tandem Diabetes Care (TNDM) announced that the t:slim X2 insulin pump with Control-IQ+ automated insulin delivery, AID, technology is now compatible with Abbott's (ABT) FreeStyle Libre 3 Plus continuous glucose monitoring, CGM, sensor in five countries. This launch expands continuous glucose monitoring choice for t:slim X2 pump users in the United Kingdom, Switzerland, Sweden, Finland, and Italy. Tandem expects to add additional countries in 2026, including Belgium, the Netherlands, and Germany. "People using AID want flexibility in the devices they use," said Jordan Pinsker, MD, chief medical officer. "The addition of Abbott's latest generation sensor expands CGM choice for people using our Control-IQ+ technology."

Tandem Diabetes Receives CE Mark for Expanded Indications of Insulin Delivery Systems

Tandem Diabetes Care announced receipt of CE mark for expanded indications of its automated insulin delivery systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes.